Halfter H - Search Results

1

High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets.

Müller-Tidow C, Schwäble J, Steffen B, Tidow N, Brandt B, Becker K, Schulze-Bahr E, Halfter H, Vogt U, Metzger R, Schneider PM, Büchner T, Brandts C, Berdel WE, Serve H. Müller-Tidow C, et al. Among authors: halfter h. Clin Cancer Res. 2004 Feb 15;10(4):1241-9. doi: 10.1158/1078-0432.ccr-0954-03. Clin Cancer Res. 2004. PMID: 14977821

2

Alterations of lymphoid enhancer factor-1 isoform expression in solid tumors and acute leukemias.

Wang W, Ji P, Steffen B, Metzger R, Schneider PM, Halfter H, Schrader M, Berdel WE, Serve H, Müller-Tidow C. Wang W, et al. Among authors: halfter h. Acta Biochim Biophys Sin (Shanghai). 2005 Mar;37(3):173-80. Acta Biochim Biophys Sin (Shanghai). 2005. PMID: 15756419 Clinical Trial.

3

Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.

Mizuki M, Fenski R, Halfter H, Matsumura I, Schmidt R, Müller C, Grüning W, Kratz-Albers K, Serve S, Steur C, Büchner T, Kienast J, Kanakura Y, Berdel WE, Serve H. Mizuki M, et al. Among authors: halfter h. Blood. 2000 Dec 1;96(12):3907-14. Blood. 2000. PMID: 11090077 Free article.

4

Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation.

Halfter H, Stögbauer F, Friedrich M, Serve S, Serve H, Ringelstein EB. Halfter H, et al. J Neurochem. 2000 Sep;75(3):973-81. doi: 10.1046/j.1471-4159.2000.0750973.x. J Neurochem. 2000. PMID: 10936178 Free article.

5

Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.

Halfter H, Friedrich M, Resch A, Kullmann M, Stögbauer F, Ringelstein EB, Hengst L. Halfter H, et al. Cancer Res. 2006 Jul 1;66(13):6530-9. doi: 10.1158/0008-5472.CAN-04-3734. Cancer Res. 2006. PMID: 16818624 Free article.

6

Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.

Halfter H, Friedrich M, Postert C, Ringelstein EB, Stögbauer F. Halfter H, et al. Mol Cell Biol Res Commun. 1999 May;1(2):109-16. doi: 10.1006/mcbr.1999.0117. Mol Cell Biol Res Commun. 1999. PMID: 10356359

7

Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.

Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F. Halfter H, et al. Brain Res Mol Brain Res. 2000 Sep 15;80(2):198-206. doi: 10.1016/s0169-328x(00)00162-5. Brain Res Mol Brain Res. 2000. PMID: 11038252

8

Characterization of 3-[(123)I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats.

Kopka K, Riemann B, Friedrich M, Winters S, Halfter H, Weckesser M, Stögbauer F, Ringelstein EB, Schober O. Kopka K, et al. Among authors: halfter h. J Neurochem. 2001 Jan;76(1):97-104. doi: 10.1046/j.1471-4159.2001.00048.x. J Neurochem. 2001. PMID: 11145982 Free article.

9

Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor.

Halfter H, Kremerskothen J, Weber J, Hacker-Klom U, Barnekow A, Ringelstein EB, Stögbauer F. Halfter H, et al. J Neurooncol. 1998 Aug;39(1):1-18. doi: 10.1023/a:1005901423332. J Neurooncol. 1998. PMID: 9760066

10

Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate.

Thier M, Roeb E, Breuer B, Bayer TA, Halfter H, Weis J. Thier M, et al. Among authors: halfter h. Cancer Lett. 2000 Feb 28;149(1-2):163-70. doi: 10.1016/s0304-3835(99)00354-7. Cancer Lett. 2000. PMID: 10737720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters